NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20/01/2024
Voltar para busca
Dado oficial do USPTO
BIOPHARM COMMUNICATIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOPHARM COMMUNICATIONS
ST13
US500000086546683Classe
35
Pedido
86546683
Registro
5500128
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
20/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35
Data de depósito
26/02/2015
Data de registro
26/06/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/01/2024
Última transação
20/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Primeiro uso
11/10/2005
Primeiro uso no comércio
11/10/2005
Código do desenho
4
Tipo de titular
16
Localização do titular
New Hope, PA, US
Examinador
HUDSON, TAMARA BREE
Unidade examinadora
L40
Localização atual
TMEG LAW OFFICE 104
Titulares e representantes
Titulares
BioPharm Communications, LLC
Representantes
Jordan A. LaVine Flaster Greenberg P C
Classificação técnica
Classes Nice
Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business marketing and promotional services in the field of healthcare; business consulting and marketing services in the field of healthcare; providing demand creation and lead generation activities and services in the field of healthcare; marketing consultationcustomer targeting consultancy services in the field of healthcare; advertising servicespromoting and marketing the goods and services of others in the healthcare field through all public communication means; advertising and marketing services provided by means of indirect methods of marketing communicationssocial mediasearch engine marketinginquiry marketinginternet marketingmobile marketingblogging and other forms of passivesharable or viral communications channels in the field of healthcare; advertising and marketing servicespromoting the goods and services of others in the field of healthcare; analysis of market research data and statistics in the field of healthcare; business management consulting with relation to strategymarketingsalesoperationproduct design particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumersbusinessesmarket trends and actions in the field of healthcare; marketing services for others in the nature of using analytics to understanding and predict consumersbusinessesmarket trends and actions; direct marketing services in the field of healthcare; collection of market research information in the field of healthcare; computerized market research services in the field of healthcare; direct marketing consulting services in the field of healthcare; market analysis and research services in the field of health care; market intelligence services in the field of healthcare; marketing analysis services in the field of healthcare; marketing and consulting services in the field of promoting and tracking the goodsservicesbrands of others through all public communication meansparticularly specializing in the use of mobilesocialprint media to drive consumer interestengagement and action in the field of healthcare; providing demand creation and lead generation activities and services in the field of healthcare; providing advertisingmarketing and promotional services for the healthcarepharmaceutical and medical industries
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
20/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/01/2024
E815
TEAS SECTION 8 & 15 RECEIVED
20/07/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
26/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
26/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2018
PUBO
PUBLISHED FOR OPPOSITION
10/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
28/02/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
28/08/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
27/02/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
25/08/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
23/02/2016
GNSL
LETTER OF SUSPENSION E-MAILED
23/02/2016
CNSL
SUSPENSION LETTER WRITTEN
23/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2016
ALIE
ASSIGNED TO LIE
18/12/2015
NREV
NOTICE OF REVIVAL - E-MAILED
10/12/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2015
PETG
PETITION TO REVIVE-GRANTED
07/12/2015
PROA
TEAS PETITION TO REVIVE RECEIVED
07/12/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/06/2015
GNRT
NON-FINAL ACTION E-MAILED
04/06/2015
CNRT
NON-FINAL ACTION WRITTEN
04/06/2015
DOCK
ASSIGNED TO EXAMINER
03/06/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
12/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2015
NWAP
NEW APPLICATION ENTERED
02/03/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOPHARM COMMUNICATIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.